Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
02/2008
02/27/2008CN101133047A Microcrystalline (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl) acetic acid
02/27/2008CN101133046A 酮酰胺的制备 -one Amide
02/27/2008CN101133045A Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
02/27/2008CN101133036A Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
02/27/2008CN101133034A Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments
02/27/2008CN101133027A Pyridine-2-carboxamide derivatives as mglur5 antagonists
02/27/2008CN101133025A Organic compounds
02/27/2008CN101133024A Amide derivatives as inhibitors of histone deacetylase
02/27/2008CN100371361C Triarylsilyl(meth)acryloyl-containing polymers for marine coating compositions
02/27/2008CN100371329C Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
02/27/2008CN100371323C Cyanopyrrolidine derivatives
02/27/2008CN100371318C Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
02/27/2008CA2660758A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
02/26/2008US7335780 intermediates for the preparation of crop protection agents; reacting 3-substituted-4,5-dihydro-1H-pyrazole compound with hydrogen halide
02/26/2008US7335777 Benzimidazole derivatives and their use for modulating the GABAA receptor complex
02/26/2008US7335774 Quinolinone derivatives
02/26/2008US7335773 induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties
02/26/2008US7335678 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1(VR1) receptor
02/26/2008US7335677 Inhibitors of dipeptidyl peptidase IV
02/26/2008US7335676 Methods for treating inflammatory conditions or inhibiting JNK
02/26/2008US7335672 Vanilloid receptor ligands and their use in treatments
02/26/2008US7335670 Specific inhibitors of the glycine transporters glyt1 and/or glyt2; psychoses, contracture, pain, Parkinson's disease, epilepsy, and sleep apnea
02/26/2008US7335665 Spirocyclic piperidines as MCH1 antagonists and uses thereof
02/26/2008US7335657 Cytokine inhibitors
02/26/2008US7335656 Medical devices employing triazine compounds and compositions thereof
02/26/2008US7335649 3-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2-hydroxy-3'-(tetrazol-5-yl)biphenyl for treatment of thrombocytopenia; colony stimulating factors
02/26/2008CA2291094C 2-oxoimidazole derivative
02/21/2008WO2008021928A2 Hepatitis c virus inhibitors
02/21/2008WO2008021927A2 Hepatitis c virus inhibitors
02/21/2008WO2008021694A1 Anthrapyridone compounds
02/21/2008WO2008021491A2 Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones
02/21/2008WO2008020902A1 Substituted spirocyclic cgrp receptor antagonists
02/21/2008WO2008020606A1 Antiangiogenic agent
02/21/2008WO2008020302A2 Heteroaromatic quinoline-based compounds as phosphodiesterase (pde) inhibitors
02/21/2008WO2008020203A1 Pyridinylquinaz0linamine derivatives and their use as b-raf inhibitors
02/21/2008WO2008020124A1 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
02/21/2008WO2008019477A1 Viral polymerase inhibitors
02/21/2008WO2007146981A3 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
02/21/2008WO2007146116A3 Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline
02/21/2008WO2007129066A8 4- (2,6-dichloro-benzoylamino) -1h-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl) -amide for the treatment of cancer
02/21/2008WO2007123855B1 Pyrazolines for controlling invertebrate pests
02/21/2008WO2007121389A3 4,4-disubstituted piperidine derivatives as nk-i and serotonin transporter inhibitors
02/21/2008WO2007117400A3 Benzoimidazol-2-yl pyridines as modulators of the histamine h4 receptor
02/21/2008WO2007103456A3 Piperazine and piperidine biaryl derivatives
02/21/2008US20080045718 Process and intermediates for the synthesis of 2-(quinolin-5-yl)-4,5 disubstituted-azole derivatives
02/21/2008US20080045706 Modulating activation state of p38 kinase protein; utilizing compounds with switch control ligands to induce or restrict conformation
02/21/2008US20080045581 Ppar active compounds
02/21/2008US20080045569 Cyclic Amine Compound and Pest Control Agent
02/21/2008US20080045550 [1-(4-chloro-3-ethoxy-benzyl)-piperidin-4-yl]-(2-chloro-pyrimidin-4-yl)-amine; somatostatin receptor subtype 5 (SSTR5) antagonists; diabetes mellitus
02/21/2008US20080045545 3-{[(4-pyrazol-1-yl-benzyl)-(pyridine-3-sulfonyl)-amino]methyl}phenoxy)-acetic acid isopropyl ester; for reducing intraocular pressure in treating glaucoma, in a mammal
02/21/2008US20080045544 Phenyl, Pyridine, Quinoline, Isoquinoline, Naphthyridine and Pyrazine Derivatives
02/21/2008US20080045542 anticarcinogenic agent, 3-{4-[3-(2-Fluoro-5-trifluoromethylphenyl)ureido]phenyl}-1H-pyrrole-2-carboxamide, for treating cancer; modulating Protein kinases, relieve the side effect of chemotherapy
02/21/2008US20080045541 Dihydropyridinone Derivatives
02/21/2008US20080045539 such as 5-{5-[(endo)-8-methyl-8-aza-bicyclo[3.2.1]oct-3-yloxy]-pyridin-2-yl}-1H-indole, having nicotinic receptors modualtory activity, used for the treatment of attention deficit disorder, senile dementia, Down's syndrome, amyotrophic lateral sclerosis, Huntington's, Pick's and Alzheimer's disease
02/21/2008US20080045528 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling
02/21/2008US20080045525 Piperazinyl-Pyridine Analogues
02/21/2008US20080045524 Selective NPY (Y5) antagonists
02/21/2008US20080045521 Phenylalanine derivatives
02/21/2008US20080045520 Substituted Pyrrolidine Derivative
02/21/2008US20080045516 Viral Polymerase Inhibitors
02/21/2008US20080045510 Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof
02/21/2008US20080045509 Substituted benzyl amine compounds
02/21/2008US20080045508 Substituted aminomethyl benzamide compounds
02/21/2008US20080045506 Pyrrolidine Derivatives as Histamine Receptors Ligands
02/21/2008US20080045505 1-(isopropyl)-4-{[4-(tetrahydro-2H-pyran4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine, used in the treatment of nervous system and psychological disorders such as Alzheimer's disease or as cognition activators
02/21/2008US20080045503 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
02/21/2008US20080045499 Preferential Inhibition of Presenilin-1
02/21/2008US20080045493 such as Parkinson's disease, schizophrenia, cognitive disorders, depression, anxiety, drug addiction, eating disorders and urogenital disorders; 4-(2,2-Difluoro-cyclopropyl)-N-[4-(1-propyl-piperidin-3-yl)-phenyl]-benzenesulfonamide
02/21/2008US20080045480 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
02/21/2008US20080044923 use of the complexes obtained as fluorescent markers, and as relaxation agents for NMR or for NMR imaging; [Eu.(1-4H).H2O]Na
02/21/2008US20080044913 Novel 8-hydroxyquinoline acetamide compound, 8-hydroxy quinoline thioamide compound and use thereof
02/21/2008US20080044881 Advanced Indolinone Based Protein Kinase Inhibitors
02/21/2008US20080044380 Hepatitis C Virus Inhibitors
02/21/2008DE102006039038A1 Neues Herstellungsverfahren New manufacturing process
02/21/2008DE102006039003A1 Neue Verbindungen New connections
02/21/2008CA2695072A1 Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones
02/21/2008CA2661093A1 Dicer substrate rna peptide conjugates and methods for rna therapeutics
02/21/2008CA2660628A1 Hepatitis c virus inhibitors
02/21/2008CA2660560A1 Pyrazine compounds, their use and methods of preparation
02/21/2008CA2660555A1 Viral polymerase inhibitors
02/21/2008CA2660520A1 Hepatitis c virus inhibitors
02/21/2008CA2660474A1 Arylpiperazine derivatives and uses thereof
02/21/2008CA2659928A1 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
02/21/2008CA2658960A1 Phenyl, pyridine and quinoline derivatives
02/21/2008CA2650932A1 Substituted spirocyclic cgrp receptor antagonists
02/20/2008EP1889845A1 Novel pleuromutilin derivatives
02/20/2008EP1889842A1 Heterocyclic compound
02/20/2008EP1889841A1 Crystal of salt of benzimidazole compound
02/20/2008EP1889838A1 Thrombopoietin mimetics
02/20/2008EP1889836A1 Novel pyridine derivative and pyrimidine derivative (3)
02/20/2008EP1889835A1 Cyclic amine derivative having substituted alkyl group
02/20/2008EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents
02/20/2008EP1888575A2 Compounds for modulating trpv3 function
02/20/2008EP1888569A1 Substituted piperidines as renin inhibitors
02/20/2008EP1888567A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
02/20/2008EP1888565A2 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
02/20/2008EP1888562A2 Dipeptidyl peptidase-iv inhibitors
02/20/2008EP1888559A2 Piperazine-piperidine antagonists and agonists of the 5-ht1a receptor
02/20/2008EP1888558A1 Bicyclic derivatives as modulators of ion channels
02/20/2008EP1888557A2 (5z)-5-(6-quinoxalinylmethylidene)-2-ý(2,4,6-trichlorophenyl)amino¨-1,3-thiazol-4(5h)-one
1 ... 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 ... 1080